Dr. Bryant is an Associate Professor of Radiation Oncology at the University Of Florida College Of Medicine. He has presented over 40 scientific and educational talks at national and international conferences. Dr. Bryant has published more than 40 peer-reviewed publications and 3 textbook chapters. He is part of the head and neck cancer team at the University of Florida that won the Top Team Effort Award in 2014 from the University of Florida Cancer Center.
Dr. Bryant was recognized in 2018 and 2019 as a Florida Top Doctor. He is the author of the recently published article “Five-Year Biochemical Results, Toxicity and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate Cancer” which has documented the efficacy and safety of proton therapy for prostate cancer in a study that included over 1,300 patients treated at the University of Florida.
Radiation Oncology – American Board of Radiology
Residency - Division of Radiation Oncology
University of Florida, Gainesville, FL
Internship – Internal Medicine
Moses Cone Memorial Hospital, Greensboro, NC
Masters – Public Health
University of North Carolina School of Public Health, Chapel Hill, NC
University of North Carolina School of Medicine, Chapel Hill, NC
Bachelor of Science – Biology
Mary Washington College, Fredericksburg, VA
Dr. Bryant’s research focuses on the long-term outcomes and quality of life of patients with prostate cancer treated with proton therapy. He published the peer-reviewed article ”Consensus Statement on Proton Therapy for Prostate Cancer” that was published in 2020 in the International Journal of Particle Therapy. In addition, he has worked on several National Institute of Health sponsored studies. Dr. Bryant has also published multiple articles on the role of radiotherapy in the management of head and neck cancers.
- A Phase II Study of Dose-Escalated Proton-Based Radiation Therapy Delivered with a Simultaneous Integrated Boost (SIB) to Intraprostatic Tumors (IPT) Visible on Pretreatment Magnetic Resonance Image
- Risk Adapted De-Intensification of Radio-Chemotherapy for Favorable Prognosis Oropharyngeal Squamous Cell Carcinoma based on HPV subtype and plasma circulating free HPV DNA Level and Clearance Rate
- Postoperative or Salvage Radiotherapy for Node Negative Prostate Cancer Following Radical Prostatectomy
- RadTox II: Prospective Observational Exploratory Clinical Study to Determine the Assay Cut-Off for the RadTox Test in Prostate Cancer Patients to Predict Gastrointestinal Radiation Toxicity Using Circulating Cell Free DNA Directly from Plasma
- A Prospective Comparative Study of Outcomes with Proton and Photon Radiation in Prostate Cancer (COMPPARE)
Celebration of Excellence Award, Top Team Effort, Department of Radiation Oncology Head and Neck Cancer Team
UF Health Cancer Center (2015)
Celebration of Excellence Award, Top Team Effort, Department of Radiation Oncology Head and Neck Cancer Team UF Health Cancer Center (2014) Chief Resident in Radiation Oncology
University of Florida (2012-2013)
“My career at UFHPTI gives me the opportunity to cure cancer patients and help them return to their normal lives.”
Find Dr. Bryant’s publications through PubMed*
*Please note, the resulting PubMed entries may not reflect a complete or accurate listing for faculty members. Many journals are not indexed by PubMed, and there may be articles by other authors of the same name listed for each search.
Overall Rating (246 reviews)
Comments (5 newest)